Trelegy Ellipta general drug use investigation (asthma)First published 05/05/2021 Last updated 10/12/2024 EU PAS number: EUPAS40313StudyFinalised
GSK Clinical Disclosure Advisor GSK Clinical Disclosure Advisor Pharma.CDR@gsk.comStudy contactPharma.CDR@gsk.com